Published in AIDS Weekly, January 15th, 2007
Study 1: Recently published research from the United States has documented the inhibition of HIV-1 integrase (IN) activity by synthetic peptides derived from the HIV-1HXB2 Pol region of the viral genome.
"Peptides deriving from the HIV-1 HXB2 Pol gene sequence were evaluated for inhibitory activity against wild-type (WT) and mutant HIV-1 IN," wrote Z. Zawahir and colleagues, University of California.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.